Colorado
Edgewise closes sale of muscular-dystrophy business
Edgewise has closed a deal to sell its muscular-dystrophy business to a French pharmaceutical company. The agreement could be worth more than $2.6M.
Edgewise has closed a deal to sell its muscular-dystrophy business to a French pharmaceutical company. The agreement could be worth more than $2.6M.
Sandia National Laboratories is rolling out COMPASS, an effort to speed up the commercialization of lab technology. National labs produce some of the world's most advanced science, but turning discoveries into commercial products can be hard.
Researchers at Sandia National Laboratories are using crystals to measure intense magnetic fields. The sensors are meant for some of the harshest experimental environments in science, including fusion research.